Clinical Trial Update: STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion of a Phase 1/2 trial evaluating STR plus an anti-PD-1 therapy in patients with locally advanced unresectable pancreatic adenocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Anti-PD-1 therapy
• STR (STR)

Snippet

Sponsor: University Hospital Hradec Kralove | Conditions: Locally Advanced Unresectable Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED